Featured Research

from universities, journals, and other organizations

Good vibrations in fight against cancer

Date:
April 18, 2012
Source:
Case Western Reserve University
Summary:
Researchers have built medicine-toting nanochains that penetrate tumors and explode a payload of chemotherapy drug into the core of cancer. In tests on rats and mice, the technology took out far more cancer cells, inhibited tumor growth better and extended life longer than traditional chemotherapy delivery.

Medicine-toting nanochains slip into tumors and explode a chemotherapy drug into hard-to-reach cores of cancer, engineers and scientists at Case Western Reserve University report.

In tests on rats and mice, the technology took out far more cancer cells, inhibited tumor growth better and extended life longer than traditional chemotherapy delivery.

All the while, the targeted delivery system used far less of the drug doxorubicin than the amount used in traditional chemotherapy, saving healthy tissue from toxic exposure.

The new delivery system and results are described in the online edition of The American Chemical Society journal ACS Nano.

"Other nanotechnology has been used to get a drug inside a tumor, but once the drug gets in the door, it stays by the door, missing most of the building," said Efstathios Karathanasis, a biomedical engineering professor and leader of the research team. "We used a different kind of nanotechnology to smuggle the drug inside the tumor and to explode the bomb, releasing the drug in its free form to spread throughout the entire tumor."

The key to the new delivery system is the tail on the doxorubicin bomb.

Karathanasis' team took magnetic nanoparticles made of iron oxide and modified the surfaces so that one would link to the next, much like Lego building blocks.

They linked three together and chemically linked a liposome sphere filled with the drug.

They then injected rat and mouse models with the nanochains, which carried only 5 to 10 percent of doxorubicin used in standard chemotherapy. The two rodents are models of two different strains of what is called triple-negative breast cancer, a highly-aggressive form of cancer treatable only with harsh chemotherapy.

The researchers started with an aggressive form, believing if the technology works on the least treatable cancers, it is likely to work with other drugs on other forms of cancers.

A day later, after nanochains had slipped from the blood stream and congregated in the tumor, the researchers placed a wire coil, called a solenoid, outside the animal models, near the tumor. Electricity passed through the solenoid creates a radiofrequency field. The field caused the magnetic tails to vibrate, breaking open the liposome spheres.

Two weeks after treatment, tumor growth in rats that received the new drug delivery was less than half that of rats treated traditionally. In rats that received two of the new treatments, tumor growth was reduced to one-tenth that of rats treated traditionally (for example clinically used doxorubicin or liposomal doxorubicin).

Rats that received one new treatment survived an average of 25 days and those treated twice, 46 days, compared to 15 days for traditionally treated rats.

Cell death, called apoptosis, within the tumor was at least 10 times greater after one treatment with the new delivery system compared to traditional treatment.

The researchers tested only for apoptosis in mice with a different triple-negative cell line. The new treatment caused nearly a 4-fold increase in cell death within the tumor.

In both the mice and rats, the drug and resulting cell death was far more widely distributed throughout the tumors with the nanochain delivery.

"There are probably different mechanisms of growth in the different models, which indicates this technology will probably work in different types of cancer," said Ruth Keri, associate professor and vice chair of the Department of Pharmacology at Case Western Reserve School of Medicine. Keri, who is also associate director for basic research at Case Comprehensive Cancer Center, assisted in the investigation.

"This is a really clever and novel approach to targeted delivery. But, we need much more testing."

During their experimenting, the team found they could control the rate of drug release by adjusting the radiofrequency used to vibrate the chain.

They plan to further explore this capability and test whether the system can block the ability of the tumor to metastasize, which is the most common cause of cancer deaths. They will also optimize the system to provide more efficient and rapid drug release, and further evaluate the effect of size and shape of the nanochains on blood circulation and tumor penetration.

Other authors include biomedical engineering graduate researcher Randall Toy; biomedical engineering undergraduate researchers Emily Tran, Jenna Pansky, Elizabeth Doolittle, Erik Schmidt, Elliott Hayden and Aaron Mayer; Mark Griswold, a professor of radiology at Case Western Reserve School of Medicine; Pubudu Peiris, a research associate at the Case Center for Imaging Research; and physics graduate researcher Lisa Bauer.


Story Source:

The above story is based on materials provided by Case Western Reserve University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Pubudu M. Peiris, Lisa Bauer, Randall Toy, Emily Tran, Jenna Pansky, Elizabeth Doolittle, Erik Schmidt, Elliott Hayden, Aaron Mayer, Ruth A. Keri, Mark A. Griswold, Efstathios Karathanasis. Enhanced Delivery of Chemotherapy to Tumors Using a Multicomponent Nanochain with Radio-Frequency-Tunable Drug Release. ACS Nano, 2012; 120413101231008 DOI: 10.1021/nn300652p

Cite This Page:

Case Western Reserve University. "Good vibrations in fight against cancer." ScienceDaily. ScienceDaily, 18 April 2012. <www.sciencedaily.com/releases/2012/04/120418095500.htm>.
Case Western Reserve University. (2012, April 18). Good vibrations in fight against cancer. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/2012/04/120418095500.htm
Case Western Reserve University. "Good vibrations in fight against cancer." ScienceDaily. www.sciencedaily.com/releases/2012/04/120418095500.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
Can Watching TV Make You Feel Like A Failure?

Can Watching TV Make You Feel Like A Failure?

Newsy (July 24, 2014) A study by German researchers claims watching TV while you're stressed out can make you feel guilty and like a failure. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins